Document Detail


Comparison of the effects of pulsed dye laser, pulsed dye laser + salicylic acid, and clobetasole propionate + salicylic acid on psoriatic plaques.
MedLine Citation:
PMID:  16393598     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Studies show that pulsed dye laser (PDL) has some clinical benefits on psoriasis with a low clearance rate. In addition, it has been suggested that applying keratolytics before treatment might be helpful in PDL therapy. Topical corticosteroids remain the most commonly prescribed agents for psoriasis. OBJECTIVE: This study was designed to compare the efficacy of the PDL treatment with that of PDL treatment after salicylic acid on psoriatic plaques. The other goal of this study was to compare the efficacy of the PDL treatment with that of clobetasol propionate treatment. METHODS: Twenty-two patients with chronic, stable psoriatic plaques that involved less than 20% of their body were included in the study. Three similar-appearing psoriasis plaques in these patients were selected. Whereas the first plaque received only PDL, the second plaque received PDL after salicylic acid, and the third plaque received clobetasol propionate ointment and salicylic acid. Evaluation of the study plaques was carried out by the modified Psoriasis Area and Severity Index (mPASI) score and by measuring the area of the plaques. RESULTS: Of the 21 patients, 19 completed the study. Although the decrease in mPASI scores was determined to be maximum for clobetasol propionate + salicylic acid-treated plaques and minimum for only PDL-treated plaques, the decrease was statistically significant in all groups when compared with baseline (p < .003). At the 3- and 6-week evaluations, there was a statistically significant difference between clobetasol propionate + salicylic acid-treated plaques and the two PDL-treated plaques (p < .003); however, the difference observed at the 9-, 12-, and 15-week evaluations was statistically significant only between clobetasol propionate + salicylic acid-treated plaques and PDL-treated plaques (p < .003). When the baseline and 15-week evaluations were compared, there was no statistically significant increase in the mean lesion areas of clobetasol propionate + salicylic acid-treated psoriatic plaques (p > .003), but there was a statistically significant increase in the mean lesion areas of two PDL-treated psoriatic plaques (p < .003). CONCLUSION: The results of this study showed that the effect of PDL could be increased when salicylic acid was added to treatment, although there was no statistically significant difference between both treatment protocols. However, clobetasol propionate + salicylic acid treatment is more effective than both PDL and PDL + salicylic acid treatment.
Authors:
Turna Ilknur; Sevgi Akarsu; Sebnem Aktan; Sebnem Ozkan
Related Documents :
17692458 - Boron removal from aqueous solutions by activated carbon impregnated with salicylic acid.
16814558 - Molecular characterization of a potato map kinase transcriptionally regulated by multip...
2883278 - The angle of internal flow as an indicator of filling and drug release properties of ca...
620868 - Effect of topical salicylic acid on animal epidermopoiesis.
9174248 - Metabolism of [5-(3)h]kynurenine in the developing rat brain in vivo: effect of intrast...
17723618 - Use of beta-cyclodextrin bonded phase with s-triazine moiety in the spacer for separati...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]     Volume:  32     ISSN:  1076-0512     ISO Abbreviation:  Dermatol Surg     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2006-01-05     Completed Date:  2006-04-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9504371     Medline TA:  Dermatol Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  49-55     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Faculty of Medicine, Dokuz Eylül University, 35340 Izmir, Turkey. turna.ilknur@deu.edu.tr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Clobetasol / administration & dosage,  analogs & derivatives*
Combined Modality Therapy
Drug Therapy, Combination
Female
Follow-Up Studies
Glucocorticoids / administration & dosage*
Humans
Keratolytic Agents / administration & dosage*
Laser Therapy, Low-Level*
Male
Middle Aged
Prospective Studies
Psoriasis / pathology,  therapy*
Salicylic Acid / administration & dosage*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Glucocorticoids; 0/Keratolytic Agents; 25122-41-2/Clobetasol; 69-72-7/Salicylic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of vascular skin lesions with the variable-pulse 595 nm pulsed dye laser.
Next Document:  New methodology and instrumentation for follicular unit extraction: lower follicle transection rates...